[1]NORWOOD DA,MONTALVAN EE,DOMINGUEZ RL,et al.Gastric cancer:emerging trends in prevention,diagnosis,and treatment[J].Gastroenterol Clin North Am,2022,51(3):501-518.
[2]CUNNINGHAM D,ALLUM WH,STENNING SP,et al.Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer[J].N Engl J Med,2006,355(1):11-20.
[3]GRAVALOS C,JIMENO A.HER2 in gastric cancer:a new prognostic factor and a novel therapeutic target[J].Ann Oncol,2008,19(9):1523-1529.
[4]刘辉,施俊.晚期胃癌治疗的研究进展[J].现代肿瘤医学,2021,29(23):4226-4229.
LIU H,SHI J.Advances in the treatment of advanced gastric cancer [J].Modern Oncology,2021,29(23):4226-4229.
[5]GERSON JN,SKARIAH S,DENLING ER,et al.Perspectives of HER2-targeting in gastric and esophageal cancer[J].Expert Opinion on Investigational Drugs,2017,26(1):531-540.
[6]MOASSER MM.The oncogene HER2:its signaling and transforming functions and its role in human cancer pathogenesis[J].Oncogene,2007,26(45):6469-6487.
[7]SINGH D,ATTRI BK,GILL RK,et al.Review on EGFR inhibitors:critical updates [J].Mini Rev Med Chem,2016,16(14):1134-1166.
[8]SHABBIR A,QURESHI MA,MIRZA T,et al.Human epidermal growth factor(Her-2) in gastric and colorectal adenocarcinoma[J].J Pak Med Assoc,2017,67(7):1085-1090.
[9]KANAYAMA K,IMAI H,USUGI E,et al.Association of HER2 gene amplification and tumor progression in early gastric cancer[J].Virchows Arch,473(5):559-565.
[10]PARK DI,YUN JW,PARK JH,et al.HER-2/neu amplification is an independent prognostic factor in gastric cancer[J].Dig Dis Sci,2006,51:1371-1379.
[11]THIERY JP.EMT:An update [J].Methods Mol Biol,2021,2179:35-39.
[12]梁姗,蒋子川,刘欢.HER2抑制上皮钙黏素表达促进人乳腺上皮细胞迁移[J].细胞与分子免疫学杂志,2017,6(33):795-799.
LIANG S,JIANG ZC,LIU H.Inhibition of epithelial cadherin expression by HER 2 promotes human mammary epithelial cell migration[J].Journal of Cellular and Molecular Immunology,2017,6(33):795-799.
[13]HARPER KL,SOSA MS,ENTENBERG D,et al.Mechanism of early dissemination and metastasis in Her2 mammary cancer[J].Nature,2016,540(7634):588-592.
[14]AI M,LIANG K,LU Y,et al.Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition[J].Cancer Biol Ther,2013,14(3):237-245.